Bayer Animal Health Gmbh competitive analysis

Explore patent oppositions filed by Bayer Animal Health Gmbh against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026
Patent NumberTitleApplicantOpposition Date
Treatment Of Coccidiosis With Intramuscular Triazine CompositionsCEVA SANT ANIMALEAug 5, 2020
Treatment Of Coccidiosis With Intramuscular Triazine CompositionsCEVA SANT ANIMALEMay 20, 2020
New Treatments With TriazinesCEVA SANT ANIMALEMar 18, 2020
Method To Improve Virus Removal In Protein PurificationF HOFFMANN LA ROCHEOct 10, 2018
Veterinary Composition For Dermal ApplicationKRKAAug 16, 2017
Immunisation Of Large Mammals With Low Doses Of RnaGLAXOSMITHKLINE BIOLOGICALS SAMar 7, 2017
Toltrazuril With Improved Dissolution PropertiesKRKAFeb 27, 2017
Use Of Hif Alpha Stabilizers For Enhancing ErythropoiesisFIBROGEN, INC.Jul 8, 2015
Use Of Hif Alpha Stabilizers For Enhancing ErythropoiesisFIBROGEN, INC.May 13, 2015

Explore Bayer Animal Health Gmbh's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026
Patent NumberPublication DateTitleTotal Oppositions
Apr 22, 2020Formulations Containing Triazinones And Iron1
Apr 12, 2017Formulations Containing Triazinones And Iron2
Mar 18, 2015Non-Systemic Control Of Parasites1

Latest PTAB cases involving Bayer Animal Health Gmbh

Discover the latest PTAB cases involving Bayer Animal Health Gmbh, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Bayer Animal Health Gmbh with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BAYER GMBHBAYER PHARMA AKTIENGESELLSCHAFTBAYER ANIMAL HEALTH4 - - -
F HOFFMANN LA ROCHE34231 - -
FIBROGEN, INC.320 - 6
GENENTECH - 123 - 66